Intermittent high single-dose ftorafur: phase i clinical trial with a pharmacologic-toxicity correlation
Hall, S.W.; Valdivieso, M.; Benjamin, R.S.
Cancer Treatment Reports 61(8): 1495-1498
1977
ISSN/ISBN: 0361-5960 PMID: 336198 Document Number: 114022
Document emailed within 1 workday
Related Documents
Aabo, K.; Mortensen, S.A.; Skovsgaard, T.; Gymoese, E. 1983: Intermittent high-dose aclarubicin in patients with advanced cancer: a phase I study with special reference to cardiac toxicity Cancer Treatment Reports 67(3): 281-282Isacoff, W.H.; Eilber, F.; Tabbarah, H.; Klein, P.; Dollinger, M.; Lemkin, S.; Sheehy, P.; Cone, L.; Rosenbloom, B.; Sieger, L.; Block, J.B. 1978: Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue Cancer Treatment Reports 62(9): 1295-1304
Van Echo, D.A.; Egorin, M.J.; Whitacre, M.Y.; Olman, E.A.; Aisner, J. 1984: Phase I clinical and pharmacologic trial of carboplatin daily for 5 days Cancer Treatment Reports 68(9): 1103-1114
Buroker, T.; Baker, L.; Correa, J.; Schwartz, L.A.; Vailtkevicius, V.K. 1977: Phase i trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers Cancer Treatment Reports 61(3): 463-467
Van der Elst, E.M.; Mbogua, J.; Operario, D.; Mutua, G.; Kuo, C.; Mugo, P.; Kanungi, J.; Singh, S.; Haberer, J.; Priddy, F.; Sanders, E.J. 2013: High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase i trial of intermittent and daily PrEP in at-risk populations in Kenya Aids and Behavior 17(6): 2162-2172
Stephenson, C.M.; Levin, R.D.; Lis, C.G. 2007: Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer Journal of the American Osteopathic Association 107(6): 212-213
Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669
Tijssen, J.G. 1998: Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results Neurology 51(3 Suppl 3): S15-S16
Jaksić, B.; Brugiatelli, M. 1988: High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCi CLL-01 trial Nouvelle Revue Francaise d'Hematologie 30(5-6): 437-442
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Nomura, M.; Suzumura, A.; Anno, H.; Miyata, E.; Koga, S.; Yamamoto, H. 1995: Clinical usefulness of MRi in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase Rinsho Shinkeigaku 35(3): 225-230
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097
Pratt, C.B.; Roberts, D.; Shanks, E.C.; Warmath, E.L. 1974: Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors Cancer Research 34(12): 3326-3331
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T. 1985: Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation Seminars in Oncology 12(2 Suppl 3: 65-74
Muggia, F.M.; Creaven, P.J.; Hansen, H.H.; Cohen, M.H.; Selawry, O.S. 1972: Phase i clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies Cancer ChemoTherapy Reports 56(4): 515-521
Kaunitz, A.M.; Portman, D.; Westhoff, C.L.; Archer, D.F.; Mishell, D.R.; Foegh, M. 2015: Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill Contraception 91(3): 204-210
Gaillat, J.; Croize, J.; Bru, J.P.; Stahl, J.P.; Le Noc, P.; Micoud, M. 1986: Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy Pathologie-Biologie 34(5): 461-464
Kasuya, H.; Kodera, Y.; Nakao, A.; Yamamura, K.; Gewen, T.; Zhiwen, W.; Hotta, Y.; Yamada, S.; Fujii, T.; Fukuda, S.; Tsurumaru, N.; Kuwahara, T.; Kikumori, T.; Koide, Y.; Fujimoto, Y.; Nakashima, T.; Hirooka, Y.; Shiku, H.; Tanaka, M.; Takesako, K.; Kondo, T.; Aleksic, B.; Kawashima, H.; Goto, H.; Nishiyama, Y. 2014: Phase i Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer Hepato-Gastroenterology 61(131): 599-605
Nishimoto, N.; Yoshizaki, K.; Maeda, K.; Kuritani, T.; Deguchi, H.; Sato, B.; Imai, N.; Suemura, M.; Kakehi, T.; Takagi, N.; Kishimoto, T. 2003: Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study Journal of Rheumatology 30(7): 1426-1435
Khan, W.A.; Saha, D.; Rahman, A.; Salam, M.A.; Bogaerts, J.; Bennish, M.L. 2002: Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial Lancet 360(9347): 1722-1727